Tonight, as I left the clinic late, I saw the cleaning staff who quietly refresh every exam room, who organize and prepare each space with care.
We often don’t see them, but their work is vital.
Thank you, truly, for all you do. ❤️
✅ 46.6% had ≥1 CMRF
❌ CMRFs were NOT independently associated with mortality
⚠️ Independent predictors of death included age, alcohol intake, MELD score, and ACLF grade 2–3 📉
New New New ❗️
Do cardiometabolic risk factors (CMRFs) worsen outcomes in alcohol-associated hepatitis (AH)?
We analyzed 936 hospitalized patients with AH across 14 countries (2015–2024).
#LiverTwitter#Hepatology#ALD#AASLD
Hepatology. 2026.
DOI: 10.1097/HEP.0000000000001780
Our @juanpabloarab & Ekaterina Smirnova, Ph.D., won a $25K pilot award to use wearable biosensors + PEth biomarkers for objective, real-world monitoring of alcohol use in liver disease patients. https://t.co/GtZoXFBPPb #livertwitter
It is so hard to find research and career mentorship in the same place (or at all). @juanpabloarab has provided that for so many of us, myself included. We have also formed fantastic friendships with each other along the way. Full of ❤️ and forever grateful.
Digestive diseases week 2026
• Adding NAC to corticosteroids did NOT improve short- or intermediate-term mortality 🙅
• No meaningful reduction in HRS/ARF or major adverse liver outcomes vs steroids alone
Time to rethink routine NAC use in severe AH? #MedX@DDWMeeting
Watching @OmarAdnanA 🏹 his excellent posters today. He is not yet in residency and has multiple posters at DDW, and an oral. Also, he is just a great person, like the rest of @juanpabloarab 's super-talented mentees. This group is seriously inspiring
@ASRG_Liver@VCU_Liver 👏
What an incredible week at #DDW2026 in Chicago! 🎉
✅ 4 Poster Presentations
✅ 1 Oral Presentation
🏆 AASLD Foundation DDW 2026 Abstract Award
📰 Special coverage by @Healio on my work.
A huge milestone in my Journey.
@juanpabloarab@LuisAntonioDiaz@BlaneyMD@ASRG_Liver
📢 NEW in @LiversMDPI: VCU team led by @RichSterlingMD finds that FIB-4 Index Predicts Long-Term Outcomes After Sustained Virologic Response in Hepatitis C Virus Patients with Cirrhosis. #livertwitter#hcv#cirrhosis https://t.co/FFOcunMcMz
Enjoying presentations at the Congress of the Romanian Association for Integrated Hepatology in the Palace of the Parliament in Bucharest, where I will speak about #MASLD and metabolic health on Wednesday. Met with GI trainees 1:1. https://t.co/IBrJvlWojo #livertwitter#romania
Alcohol is a carcinogen. Patients with alcohol liver disease (ALD) have higher cancer risk.
A large meta-analysis shows >2x increased risk of de novo malignancies in ALD patients after liver transplantation.
👉 We need systematic, intensified cancer surveillance.
Just started PCSS-MAUD by @AASLDtweets ALD SIG. Don’t miss it. Dr Ellen Green presenting on Early Detection and Interventions for unhealthy alcohol use
📢Anyone caring for patients with alcohol-associated liver disease!
This one-pager summarizes the @AASLDtweets guideline on ALD.
It is a must-have for all residents, hospitalists, and GI Fellows! @LiverFellow@geneyim#MedEd
Why do women face unique risks in MetALD?🩺
📰Our new review, "MetALD in Women", in @AGA_CGH explores sex-specific factors shaping this emerging entity.
🙏Honored to work with my mentors & collaborators @GCholankeril@KanwalFasiha@norahterrault
👉https://t.co/o092n4rK0v